Zobrazeno 1 - 5
of 5
pro vyhledávání: '"PM Levey"'
Autor:
Louise J. Jones, Nigel J Bundred, K Bulka, Darl D. Flake, Jack Cuzick, Susanne Wagner, Zaina Sangale, Jerry S. Lanchbury, Mangesh A. Thorat, R Hoff, John F. Forbes, PM Levey, Ian S. Fentiman
Publikováno v:
Cancer Research. 77:P1-09
Background: The prognostic abilities of most gene expression signatures in breast cancer are often due to detection of proliferative activity measured from expression of genes regulated as a function of cell cycle progression. Cell Cycle Progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a97ede0b93fb69d8a50e3620f8224b5
https://doi.org/10.1158/1538-7445.sabcs16-p1-09-06
https://doi.org/10.1158/1538-7445.sabcs16-p1-09-06
Autor:
Jack Cuzick, G Elia, Mangesh A. Thorat, CA Evagora, John F. Forbes, PM Levey, Ian S. Fentiman, Louise J. Jones, Nigel J Bundred
Publikováno v:
Cancer Research. 76:P3-07
Background: Majority of studies investigating prognostic role of ER and PgR expression in ductal carcinoma in situ (DCIS) have failed to show a significant relationship with recurrence. Branched evolutionary tumour growth and resulting intratumour he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::241cfcbb5823d2eefe11c5ad04a8c037
https://doi.org/10.1158/1538-7445.sabcs15-p3-07-01
https://doi.org/10.1158/1538-7445.sabcs15-p3-07-01
Autor:
Susanne Wagner, Louise J. Jones, Darl D. Flake, John F. Forbes, Jerry S. Lanchbury, Nigel J Bundred, Zaina Sangale, R Hoff, Mangesh A. Thorat, PM Levey, Ian S. Fentiman, K Bulka, Jack Cuzick
Publikováno v:
Cancer Research. 76:P3-07
Background: As compared to invasive breast cancer (IBC), HER2 is much more frequently overexpressed in ductal carcinoma in situ (DCIS). Unlike IBC, the prognostic significance of HER2 overexpression remains to be established in DCIS and large studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::877a33f51fe478df15ea11b3f1597afb
https://doi.org/10.1158/1538-7445.sabcs15-p3-07-02
https://doi.org/10.1158/1538-7445.sabcs15-p3-07-02
Autor:
Thorat MA; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.; Breast Services, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Levey PM; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Jones JL; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Pinder SE; School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.; Department of Pathology, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Bundred NJ; Manchester University NHS Foundation Trust, Wythenshawe, Manchester, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Fentiman IS; School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom., Cuzick J; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Oct 01; Vol. 27 (19), pp. 5317-5324.
Autor:
Thorat MA; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. m.thorat@qmul.ac.uk thoratmangesh@gmail.com.; School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.; Breast Services, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, United Kingdom., Levey PM; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Jones JL; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Pinder SE; School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.; Department of Pathology, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, United Kingdom., Bundred NJ; Manchester University NHS Foundation Trust, Wythenshawe, Manchester, United Kingdom.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Fentiman IS, Cuzick J; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 May 15; Vol. 27 (10), pp. 2861-2867. Date of Electronic Publication: 2021 Mar 16.